Frank X. Leonard, President, CNS Cancers US at NovoCure Ltd (NVCR), sold 7,906 shares at $75.32 ($596K) on 2023-03-02, disclosed to the SEC on 2023-03-03.
Open-market sale of $596k NVCR by President, CNS Cancers US. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.32 | 3,799 | $286K | 48.0% |
| 2 | $75.32 | 3,799 | $286K | 48.0% |
| 3 | $76.05 | 308 | $23K | 3.9% |
| Total | $75.35 avg | 7,906 | $596K | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |